Menu

Blog

Feb 10, 2023

Autofluorescence-free, imaging-guided precision therapy for rheumatoid arthritis

Posted by in categories: biotech/medical, life extension, nanotechnology

Rheumatoid arthritis (RA), known as “immortal cancer,” is a chronic, progressive autoimmune inflammatory disease. The development and application of an RA high-sensitivity theranostics probe can help to accurately monitor the progression and realize the efficient treatment of RA.

In a study published in Advanced Science, a research group led by Prof. Zhang Yun from Fujian Institute of Research on the Structure of Matter of the Chinese Academy of Sciences developed a dual-triggered theranostics based on persistent luminescence nanoparticles (PLNPs) for RA autofluorescence-free imaging-guided precise treatment and therapeutic evaluation.

The researchers first prepared a renewable near-infrared (NIR)-emitting Zn1.3 Ga1.4 Sn0.3 O4:0.5%Cr3+, 0.3%Y3+ (ZGSO) PLNPs by a facile mesoporous silica template method.

Comments are closed.